⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Threonic Acid SCHEMBL6437643 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL16609889 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL27279909 | 1.00 | PDE4A (0.67) | — | |
| L-Threonic Acid SCHEMBL113115 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL18614891 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL120198 | 1.00 | — | — | |
| L-Threonic Acid SCHEMBL29007322 | 0.97 | PDE4A (0.64) | — | |
| L-Threonic Acid SCHEMBL8684453 | 0.97 | PDE4A (0.64) | — | |
| L-Threonic Acid SCHEMBL29945675 | 0.97 | PDE4A (0.64) | — | |
| L-Threonic Acid SCHEMBL29945694 | 0.97 | PDE4A (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084884-A | Biomarker, reagent and kit for predicting alcoholic liver disease and application of biomarker | — | 2026-05-26 | — | — | CN | claimed |
| US-12630578-B2 | Methods for the production of calcium, magnesium, and zinc salts of sugar acids | DFI USA, LLC (US) | 2026-05-19 | — | — | US | claimed |
| WO-2025251988-A9 | REAGENT COMBINATION OR KIT FOR CONSTRUCTING EMBRYOID AND USE THEREOF | 广州国家实验室 | 2026-05-15 | — | — | WO | claimed |
| EP-4687872-A1 | ORAL ACTIVE INGREDIENT COMBINATION CONTAINING L-ARGININE, L-CITRULLINE, SELENITE AND WATER-SOLUBLE BORON | RFB HealthCare GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4679085-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20250381220-A1 | MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS | Neuro Supplements, LLC (US) | 2025-12-18 | — | — | US | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| CN-119504413-A | Synthesis method and application of magnesium L-threonate | 浙江天启生化股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119454679-A | Application of L-threonic acid hemicalcium salt in preparing medicine for preventing and/or treating retinal neovascularization related diseases | 深圳市人民医院 | 2025-02-18 | — | — | CN | claimed |
| CN-118866082-A | Method for evaluating cold resistance of pennisetum by using multiple sets of chemical analysis | 山东农业大学 | 2024-10-29 | — | — | CN | claimed |
| CN-1245161-A | Process for preparing chromium L-threonate, its preparing process and application | YATAI RESEARCH CENTER OF LIFE (CN) | 2000-02-23 | — | — | CN | claimed |
| CN-1228409-A | Preparation of L-threonic acid and threonete | GANJIANG PHARMACEUTICAL CO LTD (CN) | 1999-09-15 | — | — | CN | claimed |
| CN-1200366-A | Novel L-threonic acid derivatives | JUNENG YATAI LIFE SCIENCE RESE (CN) | 1998-12-02 | — | — | CN | claimed |
| EP-0417209-B1 | COMPOSITIONS AND METHODS FOR ADMINISTERING THERAPEUTICALLY ACTIVE COMPOUNDS | OXYCAL LAB INC (US) | 1997-12-10 | — | — | EP | claimed |
| EP-0417209-A4 | COMPOSITIONS AND METHODS FOR ADMINISTERING THERAPEUTICALLY ACTIVE COMPOUNDS | — | 1992-01-08 | — | — | EP | claimed |
| US-5070085-A | IMPROVING ABSORPTION/RETENTION OF ACID-FUNCTIONAL DRUGS | OXYCAL LABORATORIES, INC. (US) | 1991-12-03 | — | — | US | claimed |
| EP-0417209-A1 | COMPOSITIONS AND METHODS FOR ADMINISTERING THERAPEUTICALLY ACTIVE COMPOUNDS | OXYCAL LABORATORIES, INC. (US) | 1991-03-20 | — | — | EP | claimed |
| US-4968716-A | IMPROVEMENT OF BODY ABSORPTION AND RETENTION | OXYCAL LABORATORIES, INC. (US) | 1990-11-06 | — | — | US | claimed |
| WO-1990003167-A1 | COMPOSITIONS AND METHODS FOR ADMINISTERING THERAPEUTICALLY ACTIVE COMPOUNDS | OXYCAL LABORATORIES, INC. (US) | 1990-04-05 | — | — | WO | claimed |
| US-4822816-A | ALDONOLACTONE OR SALT OF THREONIC, XYLONIC OR LYXONIC ACID | OXYCAL LABORATORIES, INC. (US) | 1989-04-18 | — | — | US | claimed |